ACE and myocardial ischemia: BK has been suggested to be a key mediator in ischemic and pharmacological cardioprotective maneuvers via the inhibition of platelet aggregation and plasminogen activation, which could contribute to ACE-inhibitor-induced cardiovascular protection in IHD [9].